Comparative Pharmacology
Head-to-head clinical analysis: CYCLOCORT versus OXYLONE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CYCLOCORT versus OXYLONE.
CYCLOCORT vs OXYLONE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive actions. Suppresses cytokine production, inhibits phospholipase A2, and reduces prostaglandin synthesis.
Corticosteroid that binds to glucocorticoid receptors, modulating transcription of anti-inflammatory proteins and suppressing immune response.
Apply a thin film topically to affected area twice daily (morning and evening). Not for ophthalmic use.
Apply topically to affected area twice daily.
None Documented
None Documented
3.5 hours (terminal); clinical effect duration longer due to tissue binding.
Terminal elimination half-life: 1.5-2.5 hours. Clinical context: Short half-life necessitates multiple daily dosing for sustained anti-inflammatory effect; accumulation minimal with repeated dosing.
Primarily hepatic metabolism; inactive metabolites excreted renally (<1% unchanged) and in feces (biliary).
Renal: 70-90% (as metabolites, mainly 6β-hydroxycortisol and other conjugates); Biliary/fecal: <10%; Unchanged drug: <5% in urine.
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid